SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-357808
Filing Date
2013-09-05
Accepted
2013-09-05 09:15:06
Documents
7
Period of Report
2013-09-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d593087d8k.htm 8-K 20164
2 EX-5.1 d593087dex51.htm EX-5.1 13445
3 EX-10.1 d593087dex101.htm EX-10.1 54089
4 EX-10.2 d593087dex102.htm EX-10.2 106057
5 EX-99.1 d593087dex991.htm EX-99.1 8163
6 GRAPHIC g593087ex5_1pg001.jpg GRAPHIC 5734
7 GRAPHIC g593087ex99_1logo.jpg GRAPHIC 14147
  Complete submission text file 0001193125-13-357808.txt   230900
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 131079361
SIC: 2834 Pharmaceutical Preparations